Afficher la notice abrégée

dc.rights.licenseauthentificationen_US
dc.contributor.authorFURUDOÏ, Adeline
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorRIVIÈRE, Étienne
dc.contributor.authorLAZARO, Estibaliz
dc.contributor.authorFURUDOÏ, Enio
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorVIALLARD, Jean-François
dc.contributor.authorPARRENS, Marie
dc.date.accessioned2020-11-17T10:52:14Z
dc.date.available2020-11-17T10:52:14Z
dc.date.issued2018-03
dc.identifier.issn1532-0979en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/14063
dc.description.abstractEnImmune thrombocytopenia (ITP) is an acquired antibody-mediated disease, for which splenectomy remains a curative treatment. We analyzed histology and phenotypes of ITP-splenectomy specimens from 41 adult patients, with different previous ITP-specific treatments, including B-cell-depleting rituximab (RTX) or not, in an attempt to predict splenectomy success or failure on the basis of day 56 postoperative platelet counts. RTX-naive ITP-spleen samples, compared with those from a 20-patient control trauma cohort, contained the following nonspecific, ITP-evocative, white-pulp lesions: follicular helper T-cell (programmed death-1 and inducible T-cell COStimulator) expansion in reactive follicles (P=0.01 and 0.03, respectively) and regulatory T-cell (FOXP3) expansion in the T-cell zone (P=0.049). On comparing ITP-splenectomy samples that would be successful with those that would be failures, only marginal zone hyperplasia differed (P=0.017). Indeed, 13/21 (61.9%) successful splenectomy samples exhibited marginal zone hyperplasia, as opposed to 1/9 (11.1%) failed splenectomy specimens. RTX impact on ITP-splenectomy samples was characterized by white-pulp (P=0.03) and marginal zone atrophies (P=0.01), and periarteriolar T-cell-zone hyperplasia (P\textless0.0001). The results of this novel comparative study of the histologic patterns of 41 ITP patients' evocative splenic lesions enabled clear description of different ITP morphologies and phenotypes, as a function of prior treatment and splenectomy success or failure.
dc.language.isoENen_US
dc.subjectArticle RECHERCHE
dc.title.enAdult Primary Immune Thrombocytopenia: Spleen Histology Findings and Outcomes According to Rituximab Use Based on Analysis of 41 Cases
dc.typeArticle de revueen_US
dc.identifier.doi10.1097/pas.0000000000000994en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.identifier.pubmed29200102en_US
bordeaux.journalAmerican Journal of Surgical Pathologyen_US
bordeaux.page401–412en_US
bordeaux.volume42en_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires - U1034en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03194440
hal.version1
hal.date.transferred2021-04-09T13:16:01Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=American%20Journal%20of%20Surgical%20Pathology&rft.date=2018-03&rft.volume=42&rft.issue=3&rft.spage=401%E2%80%93412&rft.epage=401%E2%80%93412&rft.eissn=1532-0979&rft.issn=1532-0979&rft.au=FURUDO%C3%8F,%20Adeline&RIVI%C3%88RE,%20%C3%89tienne&LAZARO,%20Estibaliz&FURUDO%C3%8F,%20Enio&VIALLARD,%20Jean-Fran%C3%A7ois&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée